Earlier onset of type 1 diabetes linked to greater heart risk, shorter life
27,195 individuals aged 18 years and older in the Swedish National Diabetes Register who had been diagnosed with type 1 diabetes…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
Aptamers in cancer therapeutics
Dr Harleen Kaur,Senior Scientist, AstraZeneca USA, through her research paper, talks about collaborative approaches which can…
Genome editing using CRISPR-Cas9 system shows tremendous promise
Research published in Nature Medicine describes collaborative effort to reduce off-target CRISPR-Cas9 genome editing, removing…
Eisai/Biogen to advance Alzheimer’s drug, provide fresh hope
According to Eisai, the company had already contacted various regulators and plans to pursue accelerated approvals
US FDA approves Krintafel for radical cure of P. vivax malaria
First single-dose medicine to prevent the relapse of P. vivax malaria marks a major contribution towards malaria eradication…
Verseon presents anticancer drug candidates targeting multidrug resistant cancers
Verseon’s drug candidates target cancer cells by inhibiting the protein tubulin, which leads to cell cycle arrest
Helperby Therapeutics announces phase 1 results demonstrating multiple benefits of its unique…
Helperby Therapeutics presented data at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) announcing…
Lupin’s steady stride on biosims
Lupin’s biosimilar plans are reaching a crucial inflexion point, with recent positive global Phase III results of its etanercept…
Berry pigments can open new avenues for cancer treatment
The pigments can regulate a key enzyme in cancer cells
Lesaffre Human Care launches scientific papers on women’s health
Promising anti-fungal and anti-inflammatory properties for vaginal candidiasis therapy